EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elexacaftor/VX-445–mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics

Minsoo Kim, Eli Fritz McDonald, Carleen Mae P Sabusap, Bibek Timalsina, Disha Joshi, Jeong S Hong, Andras Rab, Eric J Sorscher, Lars Plate

Journal of Biological Chemistry · 2023

DOI: 10.1016/j.jbc.2023.105242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023. Verfasst von Minsoo Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Vanderbilt University, Nashville, Tennessee, USA; Program in Chemical and Physical Biology, Vanderbilt University, Nashville…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Genetic Variation, Pyrazoles. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, McGill University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) is one of the most prevalent lethal genetic diseases with over 2000 identified mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Pharmacological chaperones such as lumacaftor (VX-809), tezacaftor (VX-661), and elexacaftor (VX-445) treat mutation-induced defects by stabilizing CFTR and are called correctors. These correctors improve proper folding and thus facilitate processing and trafficking to increase the amount of functional CFTR on the cell surface. Yet, CFTR variants display differential responses to each corrector. Here, we report that variants P67L and L206W respond similarly to VX-809 but divergently to VX-445 with P67L exhibiting little rescue when treated with VX-445. We investigate the underlying cellular mechanisms of how CFTR biogenesis is altered by correctors in these variants. Affinity purification-mass spectrometry multiplexed with isobaric tandem mass tags was used to quantify CFTR protein-protein interaction changes between variants P67L and L206W. VX-445 facilitates unique proteostasis factor interactions especially in translation, folding, and degradation pathways in a CFTR variant-dependent manner. A number of these interacting proteins knocked down by siRNA, such as ribosomal subunit proteins, moderately rescued fully glycosylated P67L. Importantly, these knockdowns sensitize P67L to VX-445 and further enhance the trafficking correction of this variant. Partial inhibition of protein translation also mildly sensitizes P67L CFTR to VX-445 correction, supporting a role for translational dynamics in the rescue mechanism of VX-445. Our results provide a better understanding of VX-445 biological mechanism of action and reveal cellular targets that may sensitize nonresponsive CFTR variants to known and available correctors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGenetic VariationPyrazolesHumansBenzodioxolesGene Knockdown TechniquesHEK293 CellsMutationProtein BiosynthesisProteostasisRibosomal ProteinsPyridinesPyrrolidinesAminopyridines

Stichwörter der Autor:innen

ER quality controlElexacaftorVX-445chaperonescorrectorcystic fibrosis (CF)cystic fibrosis transmembrane conductance regulator (CFTR)interactomicsmass spectrometry (MS)protein degradationprotein synthesisprotein-protein interactionproteomicsproteostasis

Substanzen

BenzodioxolesCystic Fibrosis Transmembrane Conductance RegulatorPyrazolesRibosomal ProteinselexacaftorPyridinesPyrrolidineslumacaftorAminopyridines

Autor:innen und Institutionen

  • Department of Chemistry, Vanderbilt University, Nashville, Tennessee, USA; Program in Chemical and Physical Biology, Vanderbilt University, Nashville, Tennessee, USA.
  • Department of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
  • Department of Pediatrics, Emory University, Atlanta, Georgia, USA.
  • Department of Chemistry, Vanderbilt University, Nashville, Tennessee, USA; Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee, USA; Department of Pathology, Microbiology and Immunology, Vande…

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • McGill University
  • NIGMS
  • Cystic Fibrosis Foundation
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute
  • Vanderbilt University

Zitieren

APA

Kim, M., McDonald, E. F., Sabusap, C. M. P., Timalsina, B., Joshi, D., Hong, J. S., Rab, A., Sorscher, E. J., & Plate, L. (2023). Elexacaftor/VX-445–mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105242

Vancouver

Kim M, McDonald EF, Sabusap CMP, Timalsina B, Joshi D, Hong JS, et al. Elexacaftor/VX-445–mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics. Journal of Biological Chemistry. 2023. doi:10.1016/j.jbc.2023.105242

BibTeX
@article{Kim2023,
  author = {Kim, Minsoo and McDonald, Eli Fritz and Sabusap, Carleen Mae P and Timalsina, Bibek and Joshi, Disha and Hong, Jeong S and Rab, Andras and Sorscher, Eric J and Plate, Lars},
  title = {Elexacaftor/VX-445–mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics},
  journal = {Journal of Biological Chemistry},
  year = {2023},
  doi = {10.1016/j.jbc.2023.105242}
}
Kostenlos starten →